Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
J Rheumatol ; 23(11): 1999-2001, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8923383

ABSTRACT

Acute rheumatic fever is a nonsuppurative sequela of upper respiratory tract infection with group A streptococci. We describe our recent experience with the diagnosis and management of 3 cases of acute rheumatic fever to highlight the delays that may arise in the diagnosis of this condition. In adults, febrile polyarthritis is the most common presentation of acute rheumatic fever. Increased awareness on the part of the physician is necessary to ensure both prompt and accurate diagnosis of this cause of febrile polyarthritis.


Subject(s)
Arthritis/etiology , Respiratory Tract Infections/etiology , Rheumatic Fever/diagnosis , Streptococcal Infections/complications , Streptococcus pyogenes/isolation & purification , Adult , Arthritis/complications , Fever/etiology , Humans , Male , Middle Aged , Respiratory Tract Infections/complications , Rheumatic Fever/complications , Rheumatic Fever/therapy
4.
Clin Infect Dis ; 20(3): 657-64, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7756492

ABSTRACT

Candidal endophthalmitis is a sight-threatening ocular infection that most frequently occurs as a complication of candidemia. While amphotericin B is considered the gold standard for the treatment of most invasive fungal infections, the optimal management of candidal endophthalmitis has not been determined. Fluconazole, a triazole antifungal agent, has been shown to be effective in the management of a number of invasive fungal infections in both immunocompromised and immunocompetent hosts. We describe the clinical features and outcomes for six patients with candidal endophthalmitis who were treated with fluconazole at our institutions, and we review 21 additional cases reported in the English-language literature. In total, fluconazole has been used as the sole therapy for candidal endophthalmitis in 14 patients; 16 eyes were infected. Endophthalmitis was cured in 15 of 16 eyes (94%), including five infections that were complicated by vitreitis. Successful treatment required the administration of fluconazole (100-200 mg po) daily for approximately 2 months. In addition, fluconazole has been used in combination with pars plana vitrectomy for the successful treatment of four cases of candidal endophthalmitis that were complicated by moderate to severe vitreitis. Fluconazole appears to be a safe and effective alternative or addition to conventional treatments for the management of candidal endophthalmitis. Prospective evaluation is required to more clearly define the role of this antifungal agent in the management of ocular infections due to Candida species.


Subject(s)
Candidiasis/drug therapy , Endophthalmitis/drug therapy , Eye Infections, Fungal/drug therapy , Fluconazole/therapeutic use , Adult , Aged , Aged, 80 and over , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Drug Administration Schedule , Drug Therapy, Combination , Endophthalmitis/microbiology , Eye Infections, Fungal/microbiology , Female , Fluconazole/administration & dosage , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
5.
Clin Infect Dis ; 19(2): 339-41, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7986913

ABSTRACT

We report the successful treatment of three cases of infection due to Exophiala species. These organisms belong to the heterogeneous group of dematiaceous (darkly pigmented) fungi. Two cases of infection occurred in organ transplant recipients who were receiving immunosuppressive medications. Both of these infections remained localized to the subcutaneous tissues and were successfully treated with surgical excision of the lesions. We also describe what is to our knowledge the first reported case of prosthetic valve endocarditis due to Exophiala castellanii that was managed with a combination of medical and surgical therapies. Exophiala species remain an uncommon cause of infection. However, as the population of immunocompromised patients continues to grow and further improvements in the microbiological techniques for identification of these fungi occur, these organisms will be recognized with increasing frequency as a cause of human disease.


Subject(s)
Dermatomycoses/therapy , Endocarditis/therapy , Exophiala , Mycoses/therapy , Adult , Antifungal Agents/therapeutic use , Dermatomycoses/microbiology , Endocarditis/microbiology , Exophiala/isolation & purification , Female , Heart Transplantation , Heart Valve Prosthesis , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Male , Middle Aged , Mitral Valve
6.
Clin Infect Dis ; 17(2): 204-9, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8399868

ABSTRACT

We report the clinical, microbiological, and radiological features of four cases of multifocal osteoarticular tuberculosis, and we review the management of this condition. In each case the initial clinical diagnosis was one of malignant disease, and the possibility of tuberculous bone infection was overlooked. There was neither clinical nor radiological evidence of pulmonary involvement in any case. Antituberculous chemotherapy was initiated in two instances on the basis of histopathologic findings compatible with tuberculous osteomyelitis; such treatment was delayed in the other two cases until the diagnosis was confirmed by culture. Antituberculous chemotherapy alone was successful in three cases, while the fourth case required emergency anterior spinal decompression as well. Two patients developed additional skeletal lesions after the initiation of appropriate antituberculous chemotherapy. Multifocal osteoarticular tuberculosis must be considered in the differential diagnosis of multiple destructive skeletal lesions in all patients from areas where tuberculosis is endemic. This condition may mimic malignant disease both clinically and radiologically.


Subject(s)
Tuberculosis, Osteoarticular/therapy , Adolescent , Adult , Diagnostic Errors , Female , Humans , Magnetic Resonance Imaging , Male , Tomography, X-Ray Computed , Tuberculosis, Osteoarticular/diagnosis
7.
Clin Infect Dis ; 16(6): 792-800; discussion 801-2, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8329511

ABSTRACT

During the past few years, there has been an apparent increase in serious infections due to group A streptococci (GAS) worldwide. We describe our experience with severe invasive GAS infections in Ontario, Canada, during the past 5 years (February 1987 through December 1991). A case was defined as the isolation of GAS from blood or normally sterile tissue in association with hypotension (systolic blood pressure, < 90 mm Hg). Fifty cases were identified in patients ranging in age from 4 to 100 years (median age, 47 years); 29 (58%) of the patients died. A primary focus of infection was identified in 38 cases (76%), with soft tissue being the site involved most frequently (68%). No focus of infection was found in 12 patients, and 36 patients (72%) were bacteremic. Complications included acute respiratory distress syndrome (21 of 50), acute renal failure (20 of 50), hypocalcemia (19 of 24), elevated creatinine kinase values (21 of 27), coagulation abnormalities (15 of 21), and hepatitis (15 of 24). Eleven cases (22%) were nosocomial; one of these was secondary to another nosocomial case. Thirty-three isolates were available for M and T typing and for determination of the presence of the genes for streptococcal pyrogenic exotoxin (SPE). The most frequent types were M1T1 (10) and M12/T12 (8). Twelve isolates possessed the speA gene, and 16 isolates had the speC gene. Only three isolates possessed both speA and speC. All isolates possessed the speB gene.


Subject(s)
Shock, Septic/epidemiology , Streptococcal Infections/epidemiology , Streptococcus pyogenes , Adolescent , Adult , Aged , Aged, 80 and over , Base Sequence , Chi-Square Distribution , Child , Child, Preschool , Cross Infection/complications , Cross Infection/epidemiology , Cross Infection/mortality , Exotoxins/genetics , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Oligodeoxyribonucleotides/chemistry , Ontario/epidemiology , Polymerase Chain Reaction , Serotyping , Shock, Septic/complications , Shock, Septic/mortality , Streptococcal Infections/complications , Streptococcal Infections/mortality , Streptococcus pyogenes/classification , Streptococcus pyogenes/genetics
10.
Chest ; 101(4): 1056-9, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1555420

ABSTRACT

STUDY OBJECTIVE: To ascertain the incidence, types, morbidity, and mortality of infectious episodes in isolated lung transplant recipients. DESIGN: Retrospective chart review of patients who have undergone transplants over a six-year period in one institution. PATIENTS: Twenty-three single and 17 double lung transplants followed up between 2 and 68 months. RESULTS: Fifty-one episodes of infection occurred in the group with a slight predominance in the double lung transplants. The 32 episodes of bacterial infection constituted the largest group of infection and more than half of these were pneumonias. Organisms identified were predominantly Gram negative. While bacterial processes made up the bulk of infections, fatalities were rare. Viral and fungal infections were less common, but more often fatal. Of six cases of viral pneumonitis, two were fatal; two of five cases of invasive fungal infection were also fatal. Overall, six patients died of infection. CONCLUSION: Our findings support previous reports from heart-lung centers documenting a high rate of infectious complications, particularly pneumonia, in recipients of lung grafts. In our experience, bacterial infections are the most common (two of three infections), but have the lowest mortality. Efforts should be directed toward establishing effective prophylaxis programs and early detection of infection.


Subject(s)
Lung Transplantation , Surgical Wound Infection/diagnosis , Bacteria/isolation & purification , Fungi/isolation & purification , Graft Rejection , Humans , Immunosuppression Therapy/methods , Incidence , Lung Transplantation/statistics & numerical data , Retrospective Studies , Risk Factors , Sputum/microbiology , Surgical Wound Infection/epidemiology , Surgical Wound Infection/microbiology , Viruses/isolation & purification
13.
Rev Infect Dis ; 12(3): 440-8, 1990.
Article in English | MEDLINE | ID: mdl-2193351

ABSTRACT

Pasteurella multocida is a rare cause of adult meningitis. Close animal contact prior to onset of illness is frequent and represents the usual mode of introduction of the organism. In reports of a total of 21 cases of P. multocida meningitis in adults (this case report and 20 described previously in the English-language literature), 18 researchers commented on the occurrence of animal contact: two cases (11%) involved cat bite, 13 (72%) involved animal contact without bite, and three (17%) occurred in the absence of recognized animal contact. Clinical presentation was typical of bacterial meningitides. Overall mortality rate was 30%. The best predictors of poor outcome were initial hemodynamic instability and age greater than 60 years. Documented bacteremia (40% of cases) was not predictive of higher mortality. Effective therapy is based on early recognition of the possibility of P. multocida meningitis and prompt initiation of treatment with penicillin, ampicillin, or a third-generation cephalosporin.


Subject(s)
Bites and Stings/complications , Cats , Cellulitis/complications , Meningitis/etiology , Pasteurella Infections/etiology , Aged , Aged, 80 and over , Animals , Cellulitis/etiology , Female , Humans , Meningitis/drug therapy , Pasteurella/classification , Pasteurella Infections/drug therapy
14.
CMAJ ; 140(12): 1456-60, 1989 Jun 15.
Article in English | MEDLINE | ID: mdl-2720530

ABSTRACT

Eight patients with AIDS (acquired immune deficiency syndrome) but free of life-threatening infection were treated with the immunosuppressive drug cyclosporine for a mean of 53.9 days. The serum cyclosporine levels were maintained in the desired therapeutic range. All eight patients experienced severe toxic symptoms, which necessitated discontinuation of cyclosporine therapy in six. The serum levels of creatinine, urea and potassium rose during treatment and fell after therapy was stopped. The total leukocyte count, hemoglobin level, platelet count, total T-cell count, and T4- and T8-cell counts all fell markedly during treatment. The total leukocyte count, platelet count, and T4- and T8-cell counts rose after therapy was stopped, but the hemoglobin level remained low. No patient experienced resolution of symptoms during therapy, and the condition of all patients improved after treatment was stopped. The results of this pilot study indicate that cyclosporine does not alleviate, and may worsen, the symptoms and laboratory findings in patients with AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Cyclosporins/adverse effects , Acquired Immunodeficiency Syndrome/blood , Acquired Immunodeficiency Syndrome/immunology , Adult , Blood Cell Count , Cyclosporins/therapeutic use , Humans , Male , Pilot Projects
15.
Clin Invest Med ; 12(1): 39-43, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2920482

ABSTRACT

Oral quinolones such as ciprofloxacin are promising agents in the treatment of serious bronchopulmonary infections due to susceptible gram-negative micro-organisms such as Haemophilus influenzae, Branhamella catarrhalis, Klebsiella pneumoniae and even Pseudomonas aeruginosa. Their moderative activity against Streptococcus pneumoniae may limit the use of these agents in the treatment of acute exacerbations of chronic bronchitis and in the empiric management of community-acquired bacterial pneumonia. Further prospectively designed studies are needed to address this issue. The ability of quinolones to effectively penetrate bronchial mucosa and to be concentrated within macrophages may afford additional advantage to these agents. They should not be used as a sole agent in the treatment of aspiration pneumonia nor anaerobic pleuropulmonary disease. Quinolones are very active in experimental models of Legionnaire's disease and deserve further clinical study. Ciprofloxacin is a promising alternative to standard parenteral drugs in the management of Pseudomonas aeruginosa infections in adults with cystic fibrosis. The potential for drug interactions with theophylline must be kept in mind for patients on both of these drugs.


Subject(s)
Anti-Infective Agents/therapeutic use , Respiratory Tract Infections/drug therapy , Animals , Anti-Infective Agents/pharmacokinetics , Bronchi/metabolism , Bronchitis/drug therapy , Ciprofloxacin/therapeutic use , Cystic Fibrosis/drug therapy , Gram-Negative Bacteria , Guinea Pigs , Humans , Macrophages/metabolism , Mucous Membrane/metabolism , Pneumonia/drug therapy , Respiratory Tract Infections/microbiology
18.
J Otolaryngol ; 16(1): 10-5, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3031328

ABSTRACT

The incidence of acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) is increasing, and as head and neck manifestations of this entity are common it is important that otolaryngologists have an up-to-date knowledge of this condition. In this paper the epidemiological aspects of the disease are reviewed and the head and neck manifestations discussed. An interesting case of adenoid cystic carcinoma of the parotid arising in a patient with ARC is presented.


Subject(s)
AIDS-Related Complex/complications , Acquired Immunodeficiency Syndrome/complications , Carcinoma, Adenoid Cystic/etiology , Otorhinolaryngologic Diseases/etiology , Parotid Neoplasms/etiology , Acquired Immunodeficiency Syndrome/immunology , Adult , Humans , Immunity, Cellular , Male , Opportunistic Infections/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...